Table 2.
FNTB rs11623866 G > C Genotype | ||||||
---|---|---|---|---|---|---|
GG | GC | CC | ||||
HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
Progression-free survival | ||||||
Treatment | ||||||
TC | 1 | 1 | 1 | |||
LTC | 6.242 (2.01, 19.41) | 0.002 | 1.046 (0.44, 2.50) | 0.919 | 1.456 (0.32, 6.62) | 0.627 |
Overall survival | ||||||
Treatment | ||||||
TC | 1 | 1 | 1 | |||
LTC | 9.589 (1.89, 48.54) | 0.006 | 1.080 (0.40, 2.91) | 0.881 | 0.474 (0.04, 5.35) | 0.546 |
CI, confidence interval;
HR, hazard ratio;
LTC, lonafarnib + TC;
TC, taxane (paclitaxel) + carboplatin.